Brokerages forecast that Henry Schein, Inc. (NASDAQ:HSIC) will report earnings per share of $0.76 for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have made estimates for Henry Schein’s earnings, with the lowest EPS estimate coming in at $0.75 and the highest estimate coming in at $0.78. Henry Schein reported earnings of $0.95 per share during the same quarter last year, which would suggest a negative year over year growth rate of 20%. The business is scheduled to report its next earnings results on Tuesday, May 14th.
According to Zacks, analysts expect that Henry Schein will report full year earnings of $3.43 per share for the current year, with EPS estimates ranging from $3.38 to $3.50. For the next fiscal year, analysts anticipate that the firm will post earnings of $3.74 per share, with EPS estimates ranging from $3.62 to $3.95. Zacks Investment Research’s earnings per share averages are an average based on a survey of research analysts that that provide coverage for Henry Schein.
Henry Schein (NASDAQ:HSIC) last posted its earnings results on Wednesday, February 20th. The company reported $1.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.11 by $0.01. Henry Schein had a return on equity of 19.86% and a net margin of 4.06%. The business had revenue of $3.38 billion during the quarter, compared to the consensus estimate of $3.46 billion. During the same period in the previous year, the business earned $0.97 EPS. The business’s quarterly revenue was up 1.7% on a year-over-year basis.
HSIC has been the subject of several analyst reports. BidaskClub raised Henry Schein from a “buy” rating to a “strong-buy” rating in a research note on Thursday, December 27th. Zacks Investment Research upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Wednesday, January 30th. ValuEngine cut Henry Schein from a “hold” rating to a “sell” rating in a research report on Tuesday, January 29th. Guggenheim assumed coverage on Henry Schein in a research report on Wednesday. They set a “buy” rating and a $72.00 target price on the stock. Finally, Craig Hallum dropped their target price on Henry Schein from $96.00 to $72.00 and set a “buy” rating on the stock in a research report on Tuesday, February 19th. Seven investment analysts have rated the stock with a sell rating, six have issued a hold rating and seven have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $79.37.
HSIC opened at $61.50 on Friday. The company has a quick ratio of 0.68, a current ratio of 1.30 and a debt-to-equity ratio of 0.28. The company has a market cap of $9.19 billion, a price-to-earnings ratio of 14.89, a P/E/G ratio of 2.29 and a beta of 0.88. Henry Schein has a 52 week low of $56.58 and a 52 week high of $91.35.
In related news, Director Philip A. Laskawy sold 3,591 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $59.12, for a total value of $212,299.92. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Philip A. Laskawy sold 1,084 shares of the company’s stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $59.86, for a total value of $64,888.24. Following the completion of the sale, the director now owns 32,899 shares in the company, valued at approximately $1,969,334.14. The disclosure for this sale can be found here. Corporate insiders own 1.15% of the company’s stock.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Financial Gravity Companies Inc. acquired a new stake in Henry Schein during the 4th quarter valued at $29,000. Bruderman Asset Management LLC acquired a new stake in Henry Schein during the 4th quarter valued at $39,000. First Hawaiian Bank grew its holdings in Henry Schein by 66.7% during the 1st quarter. First Hawaiian Bank now owns 650 shares of the company’s stock valued at $39,000 after buying an additional 260 shares during the last quarter. Ipswich Investment Management Co. Inc. acquired a new stake in Henry Schein during the 4th quarter valued at $45,000. Finally, Howe & Rusling Inc. grew its holdings in Henry Schein by 200.0% during the 4th quarter. Howe & Rusling Inc. now owns 600 shares of the company’s stock valued at $47,000 after buying an additional 400 shares during the last quarter.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Story: What causes a recession?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.